Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kymera Therapeutics, Inc.(KYMR) | 4,578,008 | 2,847,541 | -1,730,467 | $381.30M | $326.53M | 37.05% | -$54.77M |
| Dyne Therapeutics, Inc.(DYN) | 9,130,465 | 6,800,099 | -2,330,366 | $165.54M | $151.03M | 17.14% | -$14.51M |
| Sionna Therapeutics, Inc.(SION) | 2,995,602 | 2,995,602 | 0 | $120.09M | $131.78M | 14.95% | +$11.68M |
| Kailera Therapeutics, Inc. | 0 | 5,171,282 | +5,171,282 | $0 | $113.92M | 12.93% | +$113.92M |
| Disc Medicine, Inc.(IRON) | 1,513,875 | 1,513,875 | 0 | $96.80M | $110.72M | 12.56% | +$13.93M |
| Q32 Bio Inc.(QTTB) | 2,092,106 | 2,717,106 | +625,000 | $13.43M | $34.62M | 3.93% | +$21.18M |
| Korro Bio, Inc.(KRRO) | 1,137,149 | 962,884 | -174,265 | $12.87M | $12.69M | 1.44% | -$181.7K |